Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,685 | -1,816 | -4,471 | -2,529 | -2,114 |
| Depreciation Amortization | 2,989 | 752 | 1,724 | 1,119 | 737 |
| Accounts receivable | 213 | -253 | 1,104 | 543 | 354 |
| Accounts payable and accrued liabilities | -423 | -55 | -45 | -98 | -1 |
| Other Working Capital | -566 | -412 | -29 | -86 | -5 |
| Other Operating Activity | 1,462 | 1,026 | 693 | 771 | 599 |
| Operating Cash Flow | $-3,010 | $-759 | $-1,025 | $-279 | $-430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -193 | -120 | -256 | -201 | -1 |
| Net Acquisitions | 29 | 29 | 3,728 | -10 | N/A |
| Other Investing Activity | 0 | 0 | -473 | -470 | 0 |
| Investing Cash Flow | $-163 | $-91 | $2,999 | $-681 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,270 | 1,410 | N/A | N/A | N/A |
| Debt Repayment | -11 | -7 | -9 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 7,340 | 7,340 | 104 |
| Other Financing Activity | -4,419 | -3 | -3,014 | -178 | -83 |
| Financing Cash Flow | $10,840 | $1,400 | $4,317 | $7,162 | $21 |
| Exchange Rate Effect | -16 | -42 | -66 | 98 | 40 |
| Beginning Cash Position | 8,293 | 8,293 | 2,068 | 2,068 | 2,068 |
| End Cash Position | 15,944 | 8,801 | 8,293 | 8,367 | 1,698 |
| Net Cash Flow | $7,651 | $508 | $6,225 | $6,299 | $-369 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,010 | -759 | -1,025 | -279 | -430 |
| Capital Expenditure | -193 | -120 | -256 | -201 | -1 |
| Free Cash Flow | -3,202 | -880 | -1,281 | -481 | -430 |